Partial immunity and SARS-CoV-2 mutations—Response

Saad-Roy CM, Morris SE, Metcalf CJE, Mina MJ, Baker RE, Farrar J, Holmes EC, Pybus OG, Graham AL, Levin SA, Grenfell BT, Wagner CE
No abstract available
Keywords:

Antibodies, Viral

,

COVID-19

,

Humans

,

Mutation

,

SARS-CoV-2

,

Spike Glycoprotein, Coronavirus